Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
- Conditions
- Asthma
- Interventions
- Device: Pressurized Metered-Dose Inhaler
- Registration Number
- NCT01714063
- Lead Sponsor
- Philips Respironics
- Brief Summary
The primary objective of this study is to determine ex vivo the amount of fluticasone deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond Valved Holding Chamber (VHC) mouthpiece and the subject's mouth during coordinated and uncoordinated actuation/inhalation maneuver.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
-
• Asthmatic children between the ages of 5 and 8 followed at Arkansas Children's Hospital.
- The subjects must be available to complete the study.
- The subject's parent(s) and/or the subject's legal guardian must provide written informed consent to participate in the study.
- The subject must provide assent when older than 7 years old.
- The subjects should have used a pMDI VHC previously and be able to use a VHC with mouthpiece.
- The subjects should have been prescribed fluticasone or another inhaled corticosteroid delivered via a pMDI VHC combination.
- Clinically stable asthma.
- Cooperative, i.e., subject should be able to follow and understand instructions.
- The subject must satisfy the study investigator about his/her fitness to participate in the study.
- Clinically significant respiratory disease in the previous 4 weeks.
- Participation in any other clinical trial in the previous 4 weeks.
- Lack of cooperation, subject cannot follow and understand instructions.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Aged 6.6- 8 years Pressurized Metered-Dose Inhaler Group 2 will consist of 16 children aged 6.6- 8 years Age 5-6.5 Pressurized Metered-Dose Inhaler Group 1 will consist of 16 children aged 5-6.5 years
- Primary Outcome Measures
Name Time Method Delivered Dose of Fluticasone (on the Filter) Day 1 This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.
Delivered Dose of Fluticasone (on the Filter) Comparing Coordinated and Uncoordinated Maneuvers Day 1 This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.
- Secondary Outcome Measures
Name Time Method Inspiratory Tidal Volume Day 1 Inspiratory tidal volume is a person's lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied. In a healthy, young human adult, tidal volume is approximately 500 mL per inspiration or 7 mL/kg of body mass.
This study compared the inspiratory tidal volume of all participants between the coordinated and uncoordinated maneuvers.Inspiratory Peak Flow Day 1 Inspiratory peak flow is a person's maximum speed of inspiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe in air.
This study compared the inspiratory peak flows of all participants between the coordinated and uncoordinated maneuvers.
Trial Locations
- Locations (1)
Arkansas Children's Hospital
🇺🇸Little Rock, Arkansas, United States